US Lifts Pause on Johnson & Johnson COVID-19 Vaccine but Warns Increased Risk of Rare Blood Clots

HNGN

24 Apr 2021 0 shares 2 views

US Lifts Pause on Johnson & Johnson COVID-19 Vaccine but Warns Increased Risk of Rare Blood Clots

US Lifts Pause on Johnson & Johnson COVID-19 Vaccine but Warns Increased Risk of Rare Blood Clots

HNGN

Published 24 Apr 2021

The Johnson & Johnson COVID-19 vaccine would be used again in the United States, the CDC and the FDA announced Friday following an 11-day halt.

You might like

Related news coverage

Health Officials Push Johnson & Johnson Vaccine Confidence

Health Officials Push Johnson & Johnson Vaccine Confidence

Newsy 26 Apr 2021

Watch VideoSince the vaccine rollout started, we've been talking about public trust and confidence in the vaccines.

Now..

Health Canada updates J&J vaccine product label to mention 'very rare' cases of blood clots
CTV News 26 Apr 2021
California man hospitalized with clot after J&J vaccination
SeattlePI.com 26 Apr 2021
J&J Vaccine Holds Lower Side Effect Risks Than Aspirin: NIH Director
RTTNews 26 Apr 2021
The Latest: Washington state resumes J&J inoculations
SeattlePI.com 25 Apr 2021

Advertisement

More coverage

J&J COVID Shot Will Now Be Administered “Immediately” In NY State After FDA Lifts Pause

J&J COVID Shot Will Now Be Administered “Immediately” In NY State After FDA Lifts Pause

Gothamist 24 Apr 2021

A vial of the Johnson and Johnson vaccine.

On Friday, the federal Food and Drug Administration lifted the pause on the..

As U.S. Leans On Vaccines To Contain Spread, COVID-19 Surges Elsewhere
Newsy 24 Apr 2021
With OK from experts, some states resume use of J&J vaccine
SeattlePI.com 24 Apr 2021
NY resumes J&J COVID vaccines ‘effective immediately’ after feds lift pause
PIX 11 24 Apr 2021
Johnson & Johnson COVID-19 vaccine unpaused in U.S. as CDC, FDA update guidance
Upworthy 24 Apr 2021